Fingerprint Dive into the research topics of 'Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: Results of a phase II Southwest Oncology Group study'. Together they form a unique fingerprint.